Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Retatrutide is a complex 39-amino-acid peptide synthesis errors, degradation, or contamination can render it ineffective or unsafe
A competitor may also claim that we are infringing its patents and that we therefore cannot practice our technology as claimed under our patent applications and patents, if issued
View: 6633 Download: 118 Times Cited: 0
US$ 24.16
US$ 28.92
US$ 24.08
